Finish line in sight for Pierrel-modoBIOTECH merger
Pierrel Research is close to inking a takeover deal with Swiss R&D firm monoBIOTECH that it says will help shape“the new paradigm of the drug discovery and development process.”
Pierrel Research is close to inking a takeover deal with Swiss R&D firm monoBIOTECH that it says will help shape“the new paradigm of the drug discovery and development process.”